Devicor Medical Products, Inc.

Devicor Medical Products, Inc. Overview

Company Headquarters: Ohio, US

Founded: 1995

Workforce: ~ 400

Company Working: Devicor Medical Products, Inc. develops and distributes medical products and technologies. The company offers the Mammotome Breast Biopsy System, Mammotome Revolve, the tetherless Mammotome Elite, Sentinel Node Biopsy systems, Neoprobe Gamma Detection System (GDS), Mammotome MammoTestTM stereotactic biopsy table, as well as a wide range of tissue markers used in the diagnostic sampling and management of breast disease. Devicor, the market leader worldwide, is dedicated to developing technologies that will assist clinicians in precisely diagnosing breast diseases, such as breast cancer, using minimally invasive techniques. The company's distribution network provides services to more than 50 countries. Furthermore, it has operations in North America, Europe, and the Asia pacific.

Strategy

Devicor Medical Products aims to achieve growth by expanding its product portfolio and geographic reach through both organic growth and acquisitions. The company is focused on expanding its market share in emerging markets with increasing healthcare needs, while also developing new products and technologies that can improve patient outcomes and reduce healthcare costs. Devicor Medical Products is investing in research and development to develop new breast biopsy and breast cancer treatment products, and is also pursuing strategic partnerships and collaborations to leverage complementary capabilities and expand its market reach. The company is committed to providing high-quality products and services to healthcare providers, and to improving the accuracy and efficiency of breast cancer diagnosis and treatment through innovation and education.

Company Snapshot

400

Employees

1995

Founded

Ohio, US

Headquarters

SWOT Analysis

Strengths

Strong brand recognition and a leading position in the breast biopsy market, with a comprehensive range of products and services.

Weaknesses

Dependence on a limited number of large customers, which may increase risk and limit growth opportunities.

Opportunities

Expansion into new product categories and therapeutic areas, such as breast cancer treatment and other interventional oncology procedures.

Threats

Intense competition from other medical technology companies in the breast biopsy and other markets.

Key Developments

Date	Approach	Development
August-2022	Product Launch	The company's first twin stage core biopsy tool, the Mammotome DualCore biopsy system, was introduced by Mammotome. In addition to the Mammotome Elite Tetherless Vacuum-Assisted Biopsy Device (tetherless VABB) and the Mammotome Revolve Dual Vacuum-Assisted Breast Biopsy System, this new core biopsy device offers another choice in the Mammotome ultrasound-guided breast biopsy portfolio (tethered VABB).
April-2021	Product Launch	Mammotome has unveiled a new line of flexible HydroMARK Breast Biopsy Site Marker applicators that are intended to improve the user experience for clinicians. By increasing compatibility with the most popular vacuum-assisted breast biopsy equipment, the expanded line of applicators makes the HydroMARK markers available to more customers in a wider range of clinical settings.

Product Offering

Devicor Medical Products, Inc.
- Breast Biopsy Products
- Sentinel Node Biopsy

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.